|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/675 | (2006.01) |
| A61K 31/4418 | (2013.01) | ||
| A61P 31/18 | (2006.01) | ||
| A61K 31/513 | (2013.01) | ||
| A61K 31/4418 | (2006.01) | ||
| A61K 31/5377 | (2013.01) | ||
| A61K 31/513 | (2006.01) | ||
| A61K 31/675 | (2013.01) | ||
| A61K 31/5377 | (2006.01) | ||
| A61P 31/18 | (2018.01) |
| (11) | Number of the document | 3600332 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18716064.3 |
| Date of filing the European patent application | 2018-03-19 | |
| (97) | Date of publication of the European application | 2020-02-05 |
| (45) | Date of publication and mention of the grant of the patent | 2023-12-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2018/023152 |
| Date | 2018-03-19 |
| (87) | Number | WO 2018/175325 |
| Date | 2018-09-27 |
| (30) | Number | Date | Country code |
| 201762473799 P | 2017-03-20 | US |
| (72) |
GARCIA LERMA, Jose, Gerardo , US
MASSUD, Ivana, Mabel , US
HENEINE, Walid, M. , US
|
| (73) |
The United States of America, as represented by
the Secretary, Department of Health and Human
Services ,
Office of Technology Transfer
National Institutes of Health
6701 Rockledge Drive, Suite 700
MSC 7788, Bethesda, Maryland 20892-7788,
US
|
| (54) | HIV POST-EXPOSURE PROPHYLAXIS |
| HIV POST-EXPOSURE PROPHYLAXIS |